Tetratherix provides FDA review update on Tegenix 510(K)
Tetratherix Ltd. announced it received a substantive update regarding its Tegenix 510(K) submission from the U.S. Food and Drug Administration.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.